5 completed, 1 recruiting. 6 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 5, Recruiting 1 |
Follow Enzymatica AB: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation Viral RNA and Virus Infectivity in Exhaled Air Before and After Use of One Dose With ColdZyme Mouth Spray ColdZyme - URTI - Viral Upper Respiratory Tract Infection | Not applicable | Recruiting | Lund University | 200 | 2025-06-30 | 2026-04-06 |
| Duration of ColdZyme® II ColdZyme - Common Cold | Not applicable | Completed | Enzymatica AB | 45 | 2019-05-07 | 2019-10-11 |
| Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate Efficacy of CMS008618 for Common Cold ColdZyme, ColdZyme Placebo - Common Cold | Not applicable | Completed | Enzymatica AB | 701 | 2019-01-28 | 2019-08-22 |
| Evaluation of the Use of Various Assessments of Common Cold Symptoms for Proof of Efficacy of ColdZyme Mouth Spray ColdZyme - Common Cold | Not applicable | Completed | Enzymatica AB | 400 | 2018-01-25 | 2019-08-21 |
| Evaluation of ColdZyme® on Experimentally Induced Common Cold. ColdZyme® mouth spray, Placebo - Common Cold | Not applicable | Completed | Enzymatica AB | 88 | 2016-03-23 | 2019-02-07 |
| Evaluation of ColdZyme® Mouth Spray on Prevention and Alleviation of Rhinovirus Induced Common Cold ColdZyme® mouth spray, Placebo - Common Cold | Not applicable | Completed | Enzymatica AB | 46 | 2013-03-01 | 2024-08-23 |
Common Cold (5)
Germany (2) · Iceland (1) · Sweden (1) · United Kingdom (1)
Bardur Sigurgeirsson, MD, PhD (1) · Patrick Mallia, MD (1) · Ralf Uebelhack, Prof. Dr. med. (1) · Ralf Uebelhack, Prof. MD (1)